EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Readmission Following Respiratory Syncytial Virus Hospitalization among Children <5 Years of Age

Yoonyoung Choi, Evan Heller, Linda Amoafo, Yue Zhang, Kaleb Miller, Abbey Loveridge, Madelyn Ruggieri, Per Gesteland, Krow Ampofo

Journal of the Pediatric Infectious Diseases Society · 2025

DOI: 10.1093/jpids/piaf036 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of the Pediatric Infectious Diseases Society, 2025. Verfasst von Yoonyoung Choi und 8 weiteren Autor:innen. Beteiligte Einrichtung: Value & Implementation, Merck & Co., Inc., Rahway, NJ, United States. Hauptthemen laut MEDLINE: Patient Readmission, Respiratory Syncytial Virus Infections, Hospitalization, Respiratory Tract Infections. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Merck Sharp & Dohme LLC, a subsidiary of Merck & Co., Inc., Rahway, New Jersey, USA, Merck Sharp & Dohme LLC.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Hospitalization with lower respiratory infection (LRI) by Respiratory Syncytial Virus (RSV) and other respiratory viruses is common in young children. However, the likelihood of readmission following RSV LRI compared to other common respiratory viral infections is unknown.

Methods

This prospective study included children <5 years and hospitalized with laboratory-confirmed RSV LRI at two hospitals in Salt Lake City, Utah, from October 31, 2019 to April 30, 2022. For comparison, we retrospectively identified children <5 years, hospitalized during the same period with Influenza virus (IV) or human metapneumovirus (hMPV) LRI. Readmissions were tracked for 1.5 years post-discharge. We calculated the incidence proportion of readmissions and estimated hazard ratios using Cox proportional hazards model with Covariate Balancing Propensity Score.

Results

Among children hospitalized with RSV, IV, and hMPV LRI, all-cause hospital readmission was common, with 30-day readmission proportions ranging between 5% and 9% and increasing to between 19% and 30%, 1.5 years post-discharge. Respiratory-related readmission varied by virus, with RSV having higher proportions, increasing to 16.8% 1.5 years post-discharge, compared to 6%-7% with IV and hMPV. After adjusting for confounders, RSV hospitalization was associated with an increased hazard of respiratory-related readmission within 1.5 years after hospitalization compared to IV (HR 3.62, 95% CI, 1.13-11.64) or hMPV (HR 3.56, 95% CI, 1.14-11.06).

Conclusion

Respiratory-related readmission proportion was higher and progressive over time among children <5 years with an index RSV admission compared to IV and hMPV. This underscores the critical need for prevention of RSV infection in infants and young children through RSV immunization strategies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Patient ReadmissionRespiratory Syncytial Virus InfectionsHospitalizationRespiratory Tract InfectionsHumansInfantFemaleMaleChild, PreschoolUtahProspective StudiesRetrospective StudiesRespiratory Syncytial Virus, HumanMetapneumovirusParamyxoviridae InfectionsInfluenza, HumanProportional Hazards ModelsIncidence

Stichwörter der Autor:innen

Respiratory Syncytial Virushuman metapneumovirusinfluenza viruslower respiratory infection hospitalizationreadmission

Autor:innen und Institutionen

  • Value & Implementation, Merck & Co., Inc., Rahway, NJ, United States.
  • Department of Pediatrics, University of Utah, Salt Lake City, UT, United States.
  • Department of Population Health Sciences, University of Utah, Salt Lake City, UT, United States.

Förderung

  • Merck Sharp & Dohme LLC, a subsidiary of Merck & Co., Inc., Rahway, New Jersey, USA
  • Merck Sharp & Dohme LLC

Zitieren

APA

Choi, Y., Heller, E., Amoafo, L., Zhang, Y., Miller, K., Loveridge, A., Ruggieri, M., Gesteland, P., & Ampofo, K. (2025). Readmission Following Respiratory Syncytial Virus Hospitalization among Children. Journal of the Pediatric Infectious Diseases Society. https://doi.org/10.1093/jpids/piaf036

Vancouver

Choi Y, Heller E, Amoafo L, Zhang Y, Miller K, Loveridge A, et al. Readmission Following Respiratory Syncytial Virus Hospitalization among Children. Journal of the Pediatric Infectious Diseases Society. 2025. doi:10.1093/jpids/piaf036

BibTeX
@article{Choi2025,
  author = {Choi, Yoonyoung and Heller, Evan and Amoafo, Linda and Zhang, Yue and Miller, Kaleb and Loveridge, Abbey and Ruggieri, Madelyn and Gesteland, Per and Ampofo, Krow},
  title = {Readmission Following Respiratory Syncytial Virus Hospitalization among Children},
  journal = {Journal of the Pediatric Infectious Diseases Society},
  year = {2025},
  doi = {10.1093/jpids/piaf036}
}
Kostenlos starten →